Skip to main content

Table 1 Characteristics of the eligible studies

From: A meta-analysis of the prevalence of Toxoplasma gondii in animals and humans in Ethiopia

Author Year of study Location Host Method Number Positive (%)
Zewdu et al. [27] 2010–2011 CE Goat ELISA 927 183 (19.74)
Gebremedhin et al. [28] 2010–2011 CE Sheep ELISA 1030 357 (34.66)
Teshale [29] 2005–2006 CSE Sheep, goat MDAT 641 480 (74.88)
Demissie and Tilahun [30] 2000–2001 CE Sheep, goat MDAT 468 159 (33.97)
Negash et al. [31] 1999–2000 CE Sheep, goat MDAT/ELISA 174 75 (43.10)
Gebremedhin and Gizaw [32] 2013–2014 SE Sheep, goat ELISA 184 48 (26.09)
Gebremedhin et al. [33] 2011–2012 CE Sheep, goat DAT 628 111 (17.68)
Gebremedhin et al. [34] 2012–2013 CE Camel MAT 385 187 (48.57)
Tilahun et al. [35] 2012 CE Chicken MAT 125 48 (38.40)
Gebremedhin et al. [36] 2012–2013 CE Chicken MAT 601 183 (30.45)
Gebremedhin et al. [37] 2014 CE Pig DAT 402 129 (32.09)
Dubey [38] 2011 CE Cat MAT 36 33 (91.67)
Tiao [39] 2012 CE Cat MAT 48 41 (85.42)
Negash et al. [31] 1999–2000 CE Cat Coprology 40 5 (12.5)
Dubey [38] 2011 CE Cat Coprology 36 8 (22.22)
Mellbin and Vahlquist [40] nr WCSE human SFT 267 102 (38.20)
De Roever–Bonnet [41] nr CE human SFT 99 47 (47.47)
Guebre Xabier et al. [42] 1990 CSE human ELISA 919 673 (73.23)
Eshete et al. [43] nr CE human ELISA 94 19 (20.21)
Woldemichael et al.[44] 1995–1996 CE human SFT/LAT 340 268 (78.82)
Negash et al. [45] 1999–2000 CE human MDAT 65 39 (60.00)
Yimer et al. [46] nr CE human ELISA 279 270 (96.77)
Shibre et al. [47]a 2005 CE human ELISA 90 80 (88.89)
Shimelis et al. [48] 2007 CE human ELISA 330 297 (90.00)
Tedla et al. [49]a 2009 CE human ELISA 456 434 (95.18)
Zemene et al. [50] 2011 SE human ELISA 201 163 (81.09)
Gebremedhin et al. [51] 2010–2011 CE human ELISA 425 346 (81.41)
Aleme et al. [52] 2011–2012 CE human ELISA 150 141 (94.00)
Walle et al. [53] nr NE human ELISA 204 161 (78.92)
Muluye et al. [54] 2012–2013 NE human LAT 170 130 (76.47)
Tadesse et al. [55] 2012 NE human LAT 422 171 (40.52)
Endris et al. [56] 2010–2011 NE human LAT 385 341 (88.57)
Zeweld et al. [57] 2012–2013 NE human ELISA 651 51 (7.83)
Yohannes et al. [58] 2013 SE human ELISA 170 150 (88.24)
  1. CE, Central Ethiopia; CSE, Central and Southern Ethiopia; DAT, direct agglutination test; ELISA, enzyme linked immunosorbent assay; LA, latex agglutination test; MAT, modified agglutination test; MDAT, modified direct agglutination test; MDAT/ELISA, modified direct agglutination test and enzyme linked immunosorbent assay; n, sample size; NE, Northern Ethiopia; nr, not reported; SE, Southern Ethiopia; SFT, Sabin-Feldman dye test; WCSE, Western, Central and Southern Ethiopia
  2. aData on T.gondii infection was collected before the trials